Studies Reveal LIMK1's Role in Muscle-brain Interneuronal Networks

Target Name: LIMK1

NCBI ID: G3984

LIMK1

Studies Reveal LIMK1's Role in Muscle-brain Interneuronal Networks

LIMK1 (LIMK1 variant 1) is a protein that is expressed in various tissues throughout the body, including the brain, pancreas, and muscle. It is a key regulator of the muscle-brain interneuronal network, which is responsible for controlling muscle movement and maintain posture.

Recent studies have identified LIMK1 as a potential drug target for various neurological and psychiatric disorders, including Alzheimer's disease, Parkinson's disease, and depression. This is because the dysregulation of LIMK1 has been observed in these conditions, and drugs that can target this protein have been shown to have therapeutic effects.

One of the key challenges in studying LIMK1 is its complex structure. While the protein is known to have a critical role in muscle-brain interneural network, its exact mechanism of action is not well understood. This is because the functions of LIMK1 are dependent on its interactions with other proteins, and the changes in these interactions that occur in various neurological and psychiatric disorders can be difficult to study.

However, recent studies have provided some insight into the functions of LIMK1. For example, one study published in the journal \"NeuroImage\" in 2019 used techniques such as immunofluorescence and biochemical assays to show that LIMK1 was involved in the regulation of muscle contractions in the brain. The study found that when LIMK1 was expressed in muscle cells, it altered the amount of muscle contractions that occurred in response to electrical stimulation, and that these changes were associated with alterations in the structure and function of the muscle-brain inter Neural Networks.

Another study published in the journal \"Brain Research\" in 2020 used a similar approach to show that LIMK1 was involved in the regulation of neuronal excitability in the brain. The study used techniques such as live-cell imaging and optogenetics to show that when LIMK1 was expressed in brain cells, it altered the levels of neurotransmitters such as dopamine and synaptophysin, and that these changes were associated with alterations in the structure and function of the neuronal network.

These studies suggest that LIMK1 plays a critical role in the regulation of muscle-brain interneuronal networks and that its dysregulation in various neurological and psychiatric disorders may be a potential drug target. However, further research is needed to fully understand its functions and to develop effective therapies that can target LIMK1.

Protein Name: LIM Domain Kinase 1

Functions: Serine/threonine-protein kinase that plays an essential role in the regulation of actin filament dynamics. Acts downstream of several Rho family GTPase signal transduction pathways (PubMed:10436159, PubMed:11832213, PubMed:12807904, PubMed:15660133, PubMed:16230460, PubMed:18028908, PubMed:22328514, PubMed:23633677). Activated by upstream kinases including ROCK1, PAK1 and PAK4, which phosphorylate LIMK1 on a threonine residue located in its activation loop (PubMed:10436159). LIMK1 subsequently phosphorylates and inactivates the actin binding/depolymerizing factors cofilin-1/CFL1, cofilin-2/CFL2 and destrin/DSTN, thereby preventing the cleavage of filamentous actin (F-actin), and stabilizing the actin cytoskeleton (PubMed:11832213, PubMed:15660133, PubMed:16230460, PubMed:23633677). In this way LIMK1 regulates several actin-dependent biological processes including cell motility, cell cycle progression, and differentiation (PubMed:11832213, PubMed:15660133, PubMed:16230460, PubMed:23633677). Phosphorylates TPPP on serine residues, thereby promoting microtubule disassembly (PubMed:18028908). Stimulates axonal outgrowth and may be involved in brain development (PubMed:18028908)

The "LIMK1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LIMK1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets